ALLK
Price
$1.11
Change
+$0.07 (+6.67%)
Updated
May 1, 1:25 PM EST
6 days until earnings call
OCUL
Price
$5.02
Change
+$0.28 (+5.91%)
Updated
May 1, 6:59 PM EST
9 days until earnings call
Ad is loading...

Compare trend and price ALLK vs OCUL

Header iconALLK vs OCUL Comparison
Open Charts ALLK vs OCULBanner chart's image
Allakos
Price$1.11
Change+$0.07 (+6.67%)
Volume$432
CapitalizationN/A
Ocular Therapeutix
Price$5.02
Change+$0.28 (+5.91%)
Volume$1.88M
CapitalizationN/A
View a ticker or compare two or three
ALLK vs OCUL Comparison Chart

Loading...

ALLKDaily Signal changed days agoGain/Loss if shorted
 
Show more...
OCULDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ALLK vs. OCUL commentary
May 01, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALLK is a Hold and OCUL is a Hold.

COMPARISON
Comparison
May 01, 2024
Stock price -- (ALLK: $1.05 vs. OCUL: $4.74)
Brand notoriety: ALLK and OCUL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALLK: 61% vs. OCUL: 79%
Market capitalization -- ALLK: $92.97M vs. OCUL: $703.75M
ALLK [@Biotechnology] is valued at $92.97M. OCUL’s [@Biotechnology] market capitalization is $703.75M. The market cap for tickers in the [@Biotechnology] industry ranges from $566.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALLK’s FA Score shows that 1 FA rating(s) are green whileOCUL’s FA Score has 0 green FA rating(s).

  • ALLK’s FA Score: 1 green, 4 red.
  • OCUL’s FA Score: 0 green, 5 red.
According to our system of comparison, ALLK is a better buy in the long-term than OCUL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALLK’s TA Score shows that 6 TA indicator(s) are bullish while OCUL’s TA Score has 4 bullish TA indicator(s).

  • ALLK’s TA Score: 6 bullish, 2 bearish.
  • OCUL’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ALLK is a better buy in the short-term than OCUL.

Price Growth

ALLK (@Biotechnology) experienced а 0.00% price change this week, while OCUL (@Biotechnology) price change was -5.20% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.37%. For the same industry, the average monthly price growth was -4.20%, and the average quarterly price growth was +1241.07%.

Reported Earning Dates

ALLK is expected to report earnings on Aug 05, 2024.

OCUL is expected to report earnings on Aug 05, 2024.

Industries' Descriptions

@Biotechnology (+3.37% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ALLK with price predictions.
OPEN
A.I.dvisor published
a Summary for OCUL with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
OCUL($704M) has a higher market cap than ALLK($93M). OCUL YTD gains are higher at: 6.278 vs. ALLK (-61.538).
ALLKOCULALLK / OCUL
Capitalization93M704M13%
EBITDAN/AN/A-
Gain YTD-61.5386.278-980%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
OCUL: Fundamental Ratings
OCUL
OUTLOOK RATING
1..100
51
VALUATION
overvalued / fair valued / undervalued
1..100
60
Fair valued
PROFIT vs RISK RATING
1..100
95
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALLKOCUL
RSI
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
63%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
82%
Declines
ODDS (%)
Bearish Trend 7 days ago
84%
Bearish Trend 7 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
ALLKDaily Signal changed days agoGain/Loss if shorted
 
Show more...
OCULDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AFNAX24.05-0.17
-0.70%
Bahl & Gaynor Income Growth A
FAIDX47.05-0.46
-0.97%
Fidelity Advisor International Discv A
ECDIX16.39-0.27
-1.62%
Eaton Vance Tax-Managed Global Div Inc C
RCMFX45.40-1.27
-2.72%
Schwartz Value Focused
IGNYX16.96-0.53
-3.03%
Delaware Ivy Natural Resources Y

ALLK and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALLK has been loosely correlated with AXON. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if ALLK jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALLK
1D Price
Change %
ALLK100%
-4.55%
AXON - ALLK
38%
Loosely correlated
+0.11%
VIR - ALLK
34%
Loosely correlated
+1.08%
PRME - ALLK
34%
Loosely correlated
+1.23%
AKRO - ALLK
33%
Loosely correlated
+1.38%
IMCR - ALLK
33%
Loosely correlated
+1.69%
More

OCUL and

Correlation & Price change

A.I.dvisor indicates that over the last year, OCUL has been loosely correlated with AMLX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if OCUL jumps, then AMLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCUL
1D Price
Change %
OCUL100%
-1.25%
AMLX - OCUL
44%
Loosely correlated
-4.74%
EYPT - OCUL
41%
Loosely correlated
-0.17%
NTLA - OCUL
41%
Loosely correlated
-2.64%
RCUS - OCUL
41%
Loosely correlated
-2.56%
SNDX - OCUL
41%
Loosely correlated
-0.70%
More